StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
KALA

KALA BIO, Inc.

KALA Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.77
-0.02 -2.30%

Key statistics

from XBRL data in SEC filings
Market cap
$14.2M
Revenue (TTM)
$3.89M
Net income (TTM)
-$19.7M
EPS (TTM)
$67.04
P/E ratio
0.0
Dividend yield
Free cash flow
-$33.3M
Cash
$1.76M
Total assets
$12.3M
Gross margin
52-week range
$0.59 – $1,030.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 23, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events May 7, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 4, 2026 8-K Director or officer change Feb 20, 2026 8-K Director or officer change Feb 5, 2026 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Amended charter or bylaws; Shareholder vote results Feb 2, 2026 8-K Delisting notice or listing-rule failure Jan 23, 2026 8-K Entered a material agreement Jan 8, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 6, 2026 8-K Other events Jan 2, 2026 8-K Changed accountants; Director or officer change Dec 29, 2025 8-K Changed accountants Dec 16, 2025 8-K Item 5.08; Other events Dec 16, 2025 8-K Entered a material agreement; Other events Dec 5, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Amended charter or bylaws Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Delisting notice or listing-rule failure Nov 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 10, 2025 8-K Exit or disposal costs; Director or officer change; Other events Oct 20, 2025 8-K/A Exit or disposal costs; Director or officer change Oct 2, 2025 8-K Triggering event accelerating an obligation Oct 1, 2025 8-K Exit or disposal costs; Other events Sep 29, 2025 8-K Item 5.08; Other events Sep 18, 2025 8-K Director or officer change Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 8, 2025 8-K Other events Jul 9, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Director or officer change Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Director or officer change Feb 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Dec 30, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change Sep 25, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024